Clinical trial

EPIC (Evaluating Perioperative Ischemia Reduction by Clonidine)

NCT00335582 · University Health Network, Toronto, Other · Unknown status

Key facts

NCT number NCT00335582
Title EPIC (Evaluating Perioperative Ischemia Reduction by Clonidine)
Official title The EPIC (Evaluating Perioperative Ischemia Reduction by Clonidine) Study: A Randomized, Double-blinded Trial of Clonidine for Reducing Cardiac Morbidity and Mortality Following Non-cardiac Surgery.
Lead sponsor University Health Network, Toronto, Other
Collaborators Canadian Anesthesiologists' Society
Status Unknown status
Phase Phase 4
Study type Interventional
Conditions Heart Disease
Intervention type Drug
Interventions clonidine hydrochloride
Enrollment 165
Start date Jun 1, 2006
Primary completion Aug 1, 2009
Completion Dec 1, 2009
First posted Jun 12, 2006
Last update posted Oct 9, 2009
Countries Canada

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies